Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Synergy of Immunotherapy and Laser Interstitial Warm Treatment: Paving a Multifaceted Path in Neuro-Oncology

Gabor Jancso

The rise of immunotherapy (IT) as an oncological treatment option has significantly improved outcomes in a variety of disease states. However, due to the distinct immunologic tumor microenvironment, its application in CNS tumors is still limited for a few reasons. Accordingly, it is significant to consider the convergence of IT with extra treatment techniques that might further develop admittance to the CNS and viability of existing IT modalities. Combining IT with localized hyperthermia (HT) generated by technologies like laser interstitial thermal therapy (LITT) is one such combination. The far-reaching immunomodulatory impacts of restricted and entire body HT have been explored for quite a while. Hyperthermia has exhibited immunostimulatory impacts at the degree of cancer cells, invulnerable cells, and the more extensive climate administering possible safe reconnaissance. An exhaustive comprehension of these impacts as well as the current and forthcoming examinations of such in mix with IT is significant in considering the future headings of neuro-oncology.